Skip to content
Screener

Cumberland Pharmaceuticals CPIX Inventory LIFO Reserve

Inventory LIFO Reserve at other companies

Organon logo
OrganonOGN
$135M-6.9%
Merck & Co. logo
Merck & Co.MRK
$1.1B+28.2%

Other financials

Income statement

See full
Revenue$166.5K-56.3%
Gross profit$7.2M-30.0%
Operating income-$3.2M-1.3%
Net income-$4.3M-477%
EPS (diluted)-$0.29-480%

Balance sheet

See full
Cash & equivalents$3.9M-76.0%
Total debt$4.7M-7.6%
Total equity$17.4M-37.7%
Total assets$62.9M-7.4%

Cash flow

See full
Operating cash flow$168.7K-80.0%
CapEx$38.3K+44.5%
Free cash flow$130.5K-84.0%

Valuation

See full
Market cap$116.72M+175%
Enterprise value$117.57M+273%
P/S3.7×+2.4×

Profitability

See full
Gross margin77.2%-7.1pp
Operating margin-30.8%+135pp
Net margin-34.9%-54.7pp
FCF margin2.2%

Returns & leverage

See full
Return on equity-48.1%-67.6pp
Debt / equity0.3×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryLIFOReserve.

The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 5:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001087294-26-000062

FAQ

What is Cumberland Pharmaceuticals's inventory LIFO reserve?
Cumberland Pharmaceuticals (CPIX) reported inventory LIFO reserve of $14.57M in Q2 2026.
What does inventory LIFO reserve mean?
This is the difference between the cost of inventory calculated using the FIFO or average cost method and the cost calculated using the LIFO method. It is used to adjust the LIFO-based inventory value to a current cost basis for analytical purposes. Investors use this to normalize earnings and inventory values when comparing companies that use different inventory accounting methods.

Ask your AI about Cumberland Pharmaceuticals's inventory lifo reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude